Matthew A. Smith

发表

PRDM1 Is Required for Mantle Cell Lymphoma Response to Bortezomib

Jianguo Tao, K. Wright, S. Desai, 2010, Molecular Cancer Research.

Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development

D. Matsui, R. Kelly, B. Jobe, 2017, Cancer investigation.

Loss of calpain 10 causes mitochondrial dysfunction during chronic hyperglycemia.

R. Schnellmann, M. Covington, Matthew A. Smith, 2012, Archives of biochemistry and biophysics.

PRDM1/Blimp-1 Controls Effector Cytokine Production in Human NK Cells

M. Caligiuri, Sheng Wei, K. Wright, 2010, The Journal of Immunology.

Tyrosine phosphoproteomics identified both co-drivers and co-targeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer RUNNING TITLE: Phosphoproteomics of EGFR-TKI resistance

E. Haura, I. Okamoto, B. Rawal, 2014 .

Calpain 10 homology modeling with CYGAK and increased lipophilicity leads to greater potency and efficacy in cells.

C. McInnes, R. Schnellmann, C. Beeson, 2012, ACS chemical biology.

Mitochondrial calpain 10 is degraded by Lon protease after oxidant injury.

R. Schnellmann, Matthew A. Smith, 2012, Archives of biochemistry and biophysics.

Signaling and Regulation Molecular Cancer Research PRDM 1 Is Required for Mantle Cell Lymphoma Response to Bortezomib

K. Wright, S. Desai, J. Tao, 2010 .

EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases.

A. Jimeno, U. Rix, M. Varella‐Garcia, 2017, Cancer research.

The Influence of Spermine on the In Situ Expression of a Protein Kinase Associated with Senescence in Marchantia polymorpha Thalli

N. Maravolo, Matthew A. Smith, 2004, International Journal of Plant Sciences.

Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers.

K. Wright, J. Pinilla-Ibarz, E. Sotomayor, 2009, Leukemia research.

MET–GRB2 Signaling-Associated Complexes Correlate with Oncogenic MET Signaling and Sensitivity to MET Kinase Inhibitors

A. Borczuk, B. Halmos, E. Haura, 2017, Clinical Cancer Research.

Cell signaling heterogeneity is modulated by both cell-intrinsic and -extrinsic mechanisms: An integrated approach to understanding targeted therapy

Eric B Haura, Alexander R A Anderson, Eunjung Kim, 2018, PLoS biology.

Novel Roles for the Transcriptional Repressor PRDM1 in Human Natural Killer Cells and Identification of an Inhibitor of its Interacting Methyltransferase G9a

Matthew A. Smith, 2011 .

MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output

T. Jenuwein, Zhi-Min Yuan, Jiandong Chen, 2010, The EMBO journal.

MDM2 recruitment of lysine methyltransferases regulates p53 transcriptional output

T. Jenuwein, Zhi-Min Yuan, Jiandong Chen, 2010, The EMBO journal.

The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation

J. Silverman, D. Matsui, David H. Wang, 2017, Annals of surgery.

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma

A. Goel, R. Kelly, B. Jobe, 2019, Oncotarget.

Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non–Small Cell Lung Cancer

E. Haura, I. Okamoto, B. Rawal, 2014, Clinical Cancer Research.

Signaling control by epidermal growth factor receptor and MET: rationale for cotargeting strategies in lung cancer.

E. Haura, Matthew A. Smith, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer

S. Altiok, E. Haura, W. Fulp, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non-Small Cell Lung Cancer with Activating Mutations of EGFR.

D. Coppola, J. Cheng, Jian-ping Guo, 2016, Cancer research.

Positive Regulatory Domain I (PRDM1) and IRF8/PU.1 Counter-regulate MHC Class II Transactivator (CIITA) Expression during Dendritic Cell Maturation*

Sheng Wei, P. Tailor, K. Ozato, 2011, The Journal of Biological Chemistry.

Histone deacetylase 8 inhibition suppresses mantle cell lymphoma viability while preserving natural killer cell function.

K. Wright, G. Wright, B. Shah, 2020, Biochemical and biophysical research communications.

Calpains, mitochondria, and apoptosis.

R. Schnellmann, Rick G Schnellmann, Matthew A Smith, 2012, Cardiovascular research.

Mechanism of interleukin-1β induced-increase in mouse intestinal permeability in vivo.

D. Ye, D. Watterson, Shuhong Guo, 2012, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Evaluation and implementation of a molecular-based protocol for the identification of enteroviruses at the Florida Department of Health - Tampa Laboratory

Matthew A. Smith, 2003 .

MA 12.05 Genomic Profiling of EGFR T790M Mutated Non-Small Cell Lung Cancer to Evaluate the Mechanisms of Resistance to Osimertinib

J. Gray, J. K. Hicks, T. Boyle, 2017 .

Annotation of human cancers with EGFR signaling–associated protein complexes using proximity ligation assays

M. Schabath, S. Altiok, E. Haura, 2015, Science Signaling.

Magnitude and duration of immune checkpoint up-regulation and changes in the immune microenvironment post chemo-radiation (CRT) in esophageal cancer.

J. Silverman, D. Matsui, David H. Wang, 2017 .

Fully Automated Protein Proximity Assay in FFPE Tissue using Caged Haptens.

Brian D. Kelly, E. Haura, Nathan W. Polaske, 2020, Bioconjugate chemistry.

Pediatric Head and Neck Extramedullary Hematopoietic Disease: Case Series and Review of the Literature

Matthew A. Smith, Erica C. Bennett, A. Morrison, 2011, The Annals of otology, rhinology, and laryngology.

Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development

D. Matsui, R. Kelly, B. Jobe, 2018, Cancer investigation.

EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases.

A. Jimeno, U. Rix, R. Doebele, 2017, Cancer research.